Quality of life, risk assessment, and safety research in liver transplantation: New frontiers in health services and outcomes research

Current Opinion in Organ Transplantation

Volumn 17, Issue 3, 2012, Pages 241-247

  Butt, Zeeshan ^a,b,c   Parikh, Neehar D ^b,c   Skaro, Anton I ^b   Ladner, Daniela ^b   Cella, David ^a,b,c  

^a Department of Medical Social Sciences ^*  (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

Author keywords

liver transplantation; outcomes; patient safety; quality of life; recipients; risk assessment

Indexed keywords

ANXIETY DISORDER; DEPRESSION; EMOTION; END STAGE LIVER DISEASE; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH SERVICE; HEALTH SURVEY; HUMAN; LIVER CELL CARCINOMA; LIVER SURGERY; LIVER TRANSPLANTATION; MEDICAL DECISION MAKING; MEDICAL ERROR; OUTCOME ASSESSMENT; PATIENT SAFETY; PHYSICAL ACTIVITY; QUALITY OF LIFE; RELATIVE; REVIEW; RISK ASSESSMENT; SOCIAL ASPECT; SURVIVAL RATE; WELLBEING;

BIOMEDICAL RESEARCH; HUMANS; LIVER DISEASES; LIVER TRANSPLANTATION; MEDICAL ERRORS; MORBIDITY; OUTCOME ASSESSMENT (HEALTH CARE); PATIENT SAFETY; QUALITY OF LIFE; RISK ASSESSMENT;

EID: 84861198902     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32835365c6     Document Type: Review

References (76)

1. Measuring Healthy Days. Atlanta, Georgia: CDC - Centers for Disease Control and Prevention; November, 2000 pp. 4-7.
2. Jay CL, Butt Z, Ladner DP, et al. A review of quality of life instruments used in liver transplantation. J Hepatol 2009; 51:949-959.
3. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30:473-483.
4. Gralnek IM, Hays RD, Kilbourne A, et al. Development and evaluation of the liver disease quality of life instrument in persons with advanced, chronic liver disease: the LDQOL 1.0. Am J Gastroenterol 2000; 95:3552-3565.
5. Saab S, Ng V, Landaverde C, et al. Development of a disease-specific questionnaire to measure health-related quality of life in liver transplant recipients. Liver Transpl 2011; 17:567-579.
6. Karam V, Castaing D, Danet C, et al. Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation. Liver Transpl 2003; 9:703-711. (Pubitemid 36874458)
7. Krasnoff JB, Vintro AQ, Ascher NL, et al. Objective measures of health-related quality of life over 24 months postliver transplantation. Clin Transpl 2005; 19:1-9. (Pubitemid 40227844)
8. Goetzmann L, Ruegg L, Stamm M, et al. Psychosocial profiles after transplantation: a 24-month follow-up of heart, lung, liver, kidney and allogeneic bone-marrow patients. Transplantation 2008; 86:662-668.
9. Goetzmann L, Wagner-Huber R, Klaghofer R, et al. Waiting for a liver transplant: psychosocial well being, spirituality, and need for counselling. Transpl Proc 2006; 38:2931-2936. (Pubitemid 44737969)
10. Parikh ND, Ladner D, Abecassis M, Butt Z. Quality of life for donors after living donor liver transplantation: a review of the literature. Liver Transpl 2010; 16:1352-1358.
11. Russell RT, Feurer ID, Wisawatapnimit P, et al. The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation. J Gastrointestin Surg 2008; 12:138-144.
12. Kalaitzakis E, Josefsson A, Castedal M, et al. Factors related to fatigue in patients with cirrhosis before and after liver transplantation. Clin Gastroenter-ol Hepatol 2012; 10:174-181, 181.
13. Painter P, Krasnoff J, Paul SM, Ascher NL. Physical activity and health-related quality of life in liver transplant recipients. Liver Transpl 2001; 7:213-219. (Pubitemid 32243816)
14. Huda A, Newcomer R, Harrington C, et al. High rate of unemployment after liver transplantation: analysis of the United Network for Organ Sharing database. Liver Transpl 2012; 18:89-99.
15. Gotardo DR, Strauss E, Teixeira MC, Machado MC. Liver transplantation and quality of life: relevance of a specific liver disease questionnaire. Liver Int 2008; 28:99-106.
16. Rodrigue JR, Nelson DR, Reed AI, et al. Is model for end-stage liver disease score associated with quality of life after liver transplantation? Prog Transplant 2011; 21:207-214.
17. Saab S, Ibrahim AB, Shpaner A, et al. MELD fails to measure quality of life in liver transplant candidates. Liver Transpl 2005; 11:218-223. (Pubitemid 40268220)
18. Volk ML, Hagan M. Organ quality and quality of life after liver transplantation. Liver Transpl 2011; 17:1443-1447.
19. Collis I, Burroughs A, Rolles K, Lloyd G. Psychiatric and social outcome of liver transplantation. Br J Psychiatry 1995; 166:521-524.
20. Lahteenmaki A, Hockerstedt K, Kajaste S, Huttunen M. Quality of life before and after liver transplantation: experiences with 7 patients with primary biliary cirrhosis in a 2-year follow-up. Transpl Int 1992; 5 (Suppl 1):S705-S707.
21. Rothenhausler HB, Ehrentraut S, Kapfhammer HP, et al. Psychiatric and psychosocial outcome of orthotopic liver transplantation. Psychother Psy-chosom 2002; 71:285-297. (Pubitemid 35007653)
22. Santos Junior R, Miyazaki MC, Domingos NA, et al. Patients undergoing liver transplantation: psychosocial characteristics, depressive symptoms, and quality of life. Transplant Proc 2008; 40:802-804. (Pubitemid 351608661)
23. Goetzmann L, Klaghofer R, Wagner-Huber R, et al. Psychosocial vulnerability predicts psychosocial outcome after an organ transplant: results of a prospective study with lung, liver, and bone-marrow patients. J Psychosom Res 2007; 62:93-100. (Pubitemid 44937344)
24. DiMartini A, Dew MA, Chaiffetz D, et al. Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant 2011; 11:1287-1295.
25. Langenbach M, Schmeisser N, Albus C, Decker O. Comparison of social support and psychosocial stress after heart and liver transplantation. Transplant Proc 2008; 40:938-939. (Pubitemid 351794294)
26. Sainz-Barriga M, Baccarani U, Scudeller L, et al. Quality-of-life assessment before and after liver transplantation. Transpl Proc 2005; 37:2601-2604. (Pubitemid 41354684)
27. Blanch J, Sureda B, Flavia M, et al. Psychosocial adjustment to orthotopic liver transplantation in 266 recipients. Liver Transpl 2004; 10:228-234. (Pubitemid 38240121)
28. Littlefield C, Abbey S, Fiducia D, et al. Quality of life following transplantation of the heart, liver, and lungs. Gen Hosp Psychiatry 1996; 18 (6 Suppl):36S- 47S.
29. Saab S, Bownik H, Ayoub N, et al. Differences in health-related quality of life scores after orthotopic liver transplantation with respect to selected socio-economic factors. Liver Transpl 2011; 17:580-590.
30. Sharif F, Mohebbi S, Tabatabaee HR, et al. Effects of psycho-educational intervention on health-related quality of life (QOL) of patients with chronic liver disease referring to Shiraz University of Medical Sciences. Health Qual Life Outcomes 2005; 3:81.
31. Krasnoff JB, Vintro AQ, Ascher NL, et al. A randomized trial of exercise and dietary counseling after liver transplantation. Am J Transpl 2006; 6:1896-1905. (Pubitemid 44024962)
32. Organ Procurement and Transplantation Network (OPTN) SRoTRS. OPTN/ SRTR 2010 annual data report. Rockville, MD: Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation; 2011.
33. Axelrod DA, Schnitzler M, Salvalaggio PR, et al. The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant 2007; 7:990-997. (Pubitemid 46481202)
34. Dutkowski P, Oberkofler CE, Slankamenac K, et al. Are there better guidelines for allocation in liver transplantation? A novel score targeting justice and utility in the model for end-stage liver disease era. Ann Surg 2011; 254:745-753.
35. Xia VW, Taniguchi M, Steadman RH. The changing face of patients presenting for liver transplantation. Curr Opin Organ Transplant 2008; 13:280-284.
36. Jay C, Ladner D, Wang E, et al. A comprehensive risk assessment of mortality following donation after cardiac death liver transplant: an analysis of the national registry. J Hepatol 2011; 55:808-813.
37. Mathur AK, Heimbach J, Steffick DE, et al. Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant 2010; 10:2512-2519.
38. Kadry Z, Schaefer EW, Uemura T, et al. Impact of geographic disparity on liver allocation for hepatocellular cancer in the United States. J Hepatol 2012; 56:618-625.
39. Salem R, Lewandowski RJ, Kulik L, et al. Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma. Gastroenterology 2011; 140:497-507 e2.
40. Washburn K, Edwards E, Harper A, Freeman R. Hepatocellular carcinoma patients are advantaged in the current liver transplant allocation system. Am J Transplant 2010; 10:1643-1648.
41. Cucchetti A, Cescon M, Bigonzi E, et al. Priority of candidates with hepato-cellular carcinoma awaiting liver transplantation can be reduced after successful bridge therapy. Liver Transpl 2011; 17:1344-1354.
42. Clavien PA, Lesurtel M, Bossuyt PM, et al. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol 2012; 13:e11-e22.
43. Skaro AI, Wang E, LyuksemburgV,Abecassis M. Donation after cardiac death liver transplantation: time for policy to catch up with practice. Liver Transpl 2012; 18:5-8.
44. Foley DP, Fernandez LA, Leverson G,et al. Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg 2011; 253:817-825.
45. Jay CL, Lyuksemburg V, Ladner DP, et al. Ischemic cholangiopathy after controlled donation after cardiac death liver transplantation: a meta-analysis. Ann Surg 2011; 253:259-264.
46. Jay C, Skaro A, Ladner D, et al. The comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: recognizing who can benefit. Liver Transpl (in press).
47. Berg CL, Merion RM, Shearon TH, et al. Liver transplant recipient survival benefit with living donation in the model for endstage liver disease allocation era. Hepatology 2011; 54:1313-1321.
48. Olthoff KM, Abecassis MM, Emond JC, et al. Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl 2011; 17:789-797.
49. Gillespie BW, Merion RM, Ortiz-Rios E, et al. Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant 2010; 10:1621-1633.
50. Institute of Medicine. To Err is Human: Building a Safer Health System. In: Kohn, L, Corrigan JM, Donaldson MS, eds. Committee on Quality of Health care in America, editor. Shaping the Future of Health, National Academcy Press; Washington, D.C.: 1999.
51. Thomas EJ, Studdert DM, Burstin HR, et al. Incidence and types of adverse events and negligent care in Utah and Colorado. Med Care 2000; 38:261-271.
52. Weingart SN, Wilson RM, Gibberd RW, Harrison B. Epidemiology of medical error. BMJ 2000; 320:774-777. (Pubitemid 30179431)
53. Ladner D, Ross O, Skaro A, et al. Safety issues identified by proactive liver transplant safety debriefing. Hepatology 2011; 54 (Suppl 1): 386A.
54. Leape LL. Institute of Medicine medical error figures are not exaggerated. JAMA 2000; 284:95-97. (Pubitemid 30445670)
55. Gawande A. Complications: A Surgeon's Notes on an Imperfect Science. New York, New York: Picador; 2003.
56. Warren J. Death of teenage transplant recipient due to blood type mix-up shines spotlight on medical errors. Transplant News 2003.
57. Gallagher TH, Waterman AD, Ebers AG, et al. Patients' and physicians' attitudes regarding the disclosure of medical errors. JAMA 2003; 289:1001-1007. (Pubitemid 37432931)
58. Gallagher TH, Studdert D, Levinson W. Disclosing harmful medical errors to patients. N Engl J Med 2007; 356:2713-2719. (Pubitemid 47001040)
59. CMS Improves Patient Safety for Medicare and Medicaid by Addressing Never Events. [database on the Internet] (2008). http://www.cms.gov/apps/media/press/ factsheet.asp?Counter=3224&intNumPerPage=10&checkDate=&checkKey= &srchType=1&numDays=3500&srchOpt=0&srchData=&keywordType= All&chkNewsType=6&intPage=&showAll=&pYear=&year= &desc=false&cboOrder=date. [Accessed 21 March 2012].
60. Ingraham AM, Richards KE, Hall BL, Ko CY. Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. Adv Surg 2010; 44:251-267
61. Medicare takes new steps to help make your hospital stay safer [database on the Internet] (2008). http://www.cms.hhs.gov/apps/media/press/factsheet. asp?Counter=3227&intNumPerPage=1. [Accessed 21 March 2012].
62. Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33:464-470. (Pubitemid 32119037)
63. Trzeciak S, Sharer R, Piper D, et al. Infections and severe sepsis in solid-organ transplant patients admitted from a university-based ED. Am J Emerg Med 2004; 22:530-533. (Pubitemid 40143231)
64. Campbell DA Jr, Henderson WG, Englesbe MJ, et al. Surgical site infection prevention: the importance of operative duration and blood transfusion: results of the first American College of Surgeons-National Surgical Quality Improvement Program Best Practices Initiative. J Am Coll Surg 2008; 207:810-820.
65. Vogel TR, Dombrovskiy VY, Lowry SF. In-hospital delay of elective surgery for high volume procedures: the impact on infectious complications. J Am Coll Surg 2010; 211:784-790.
66. Society of Actuary Health. The Economic Measurement of Medical Errors: Milliman, Inc, 2010.
67. Board on Health Care Services. Preventing medical errors. 2007. Aspden P, Wolcott J, Bootman JL, Cronenwett LR, editors. National Academies Press; Washington D.C.
68. Friedman AL, Lee KC, Lee GD. Errors in ABO labeling of deceased donor kidneys: case reports and approach to ensuring patient safety. Am J Transplant 2007; 7:480-483. (Pubitemid 46096345)
69. Singh N. Infectious diseases in the liver transplant recipient. Semin Gastro-intest Dis 1998; 9:136-146. (Pubitemid 28403096)
70. Ploeg RJ, D'Alessandro AM, Knechtle SJ, et al. Risk factors for primary dysfunction after liver transplantation: a multivariate analysis. Transplantation 1993; 55:807-813. (Pubitemid 23122053)
71. Pokorny H, Gruenberger T, Soliman T, et al. Organ survival after primary dysfunction of liver grafts in clinical orthotopic liver transplantation. Transpl Int 2000; 13 (Suppl 1):S154-S157.
72. Cook RI, Wreathall J, Smith A, et al. Probabilistic risk assessment of accidental ABO-incompatible thoracic organ transplantation before and after 2003. Transplantation 2007; 84:1602-1609.
73. van der Vliet JA, Tidow G, Kootstra G, et al. Transplantation of contaminated organs. Br J Surg 1980; 67:596-598. (Pubitemid 10056814)
74. O'Hara DA, Carson NJ. Reporting of adverse events in hospitals in Victoria, 1994-1995. Med J Aust 1997; 166:460-463. (Pubitemid 27199212)
75. Ross O, McNatt G, Ladner D, et al. Adult living donor liver transplantation safety: a systematic literature review. Am J Transplant 2009; 9:700.
76. Commission Electrotechnique Internationale. Commission electrotechnique internationale. Analysis techniques for system reliability: procedure for failure mode and effects analysis (FMEA). 2nd ed. International Electrotechnical Commission. Geneva, Switzerland, 2006.